on StageZero Life Sciences Ltd (NASDAQ:SZLSF)
StageZero Life Sciences Provides Update on 2023 Financials Amid FFCTO
StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF), an integrated healthcare company, has announced an update on the filing of its 2023 financials. The company is under a Failure to File Cease Trade Order (FFCTO) and aims to meet the Ontario Securities Commission's deadline by July 8, 2024.
The delay was initially announced on April 2, 2024, due to insufficient financial resources to pay auditors. The audit is nearly complete, and StageZero is in the process of full payment before the filing deadline.
The FFCTO restricts trading of the company's securities until the financials are filed. If completed within 90 days of the order, the filings will serve as the company's application to revoke the FFCTO.
StageZero confirms no other undisclosed material information concerning its affairs as of this announcement.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all StageZero Life Sciences Ltd news